Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
Immune checkpoint inhibitors (ICIs) have shown encouraging outcomes against Lynch syndrome (LS)-associated colorectal cancer (CRC) and endometrial cancer with mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H). However, there is as yet no clarity on the safety and efficacy of imm...
Saved in:
Main Authors: | Yu-Ting Ma (Author), Yan Li (Author), Li Yan (Author), Fang Hua (Author), Dong-Guan Wang (Author), Guo-Ying Xu (Author), Hong-Lan Yang (Author), Ying-Jie Xue (Author), Ye-Jun Qin (Author), Dan Sha (Author), Hao Ning (Author), Miao-Qing Zhao (Author), Zhi-Gang Yao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma
by: Yu-Ting Ma, et al.
Published: (2023) -
PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report
by: YunYi Du, et al.
Published: (2022) -
Concordance between immunohistochemistry and MSI analysis for detection of MMR/MSI status in colorectal cancer patients
by: Muhammad Ishaque Faizee, et al.
Published: (2024) -
Molecular Profiling of H-MSI/dMMR/for Endometrial Cancer Patients: "New Challenges in Diagnostic Routine Practice"
by: Riccardo Adorisio, et al.
Published: (2024) -
Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation
by: Aoife J McCarthy, et al.
Published: (2019)